2026 ICD-10-CM Diagnosis Code D68.318Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

ICD-10-CM Codes›D50–D89›D65-D69›D68

ICD-10-CM D68.318
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D68.318 is a billable ICD-10-CM diagnosis code for other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as acquired coagulation factor inhibitor disorder. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Coagulation and hemorrhagic disorders.

Code Identity

ICD-10-CM Code
D68.318
Billable Status
Yes — Valid for Submission
Code Describes
Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
Short Description
Oth hemorrhagic disord d/t intrns circ anticoag,antib,inhib
Parent Code
D68.31
Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

Code Classification

ChapterD50–D89Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
SectionD65-D69Coagulation defects, purpura and other hemorrhagic conditions
CategoryD68Other coagulation defects
This CodeD68.318Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acquired coagulation factor inhibitor disorder
  • Drug-induced coagulation inhibitor disorder
  • Factor I inhibitor disorder
  • Hemorrhagic disorder due to antithrombinemia
  • Hemorrhagic disorder due to circulating anticoagulants
  • Hemorrhagic disorder due to increase in anti-11a
  • Hemorrhagic disorder due to increase in anti-9a
  • Hemorrhagic disorder due to increase in anti-VIIIa

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Antithromboplastinemia
  • Antithromboplastinogenemia
  • Hemorrhagic disorder due to intrinsic increase in antithrombin
  • Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
  • Hemorrhagic disorder due to intrinsic increase in anti-IXa
  • Hemorrhagic disorder due to intrinsic increase in anti-XIa

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Anticoagulant, circulating(intrinsic)
    • Antithromboplastinemia
    • Antithromboplastinogenemia
    • Circulating anticoagulants
    • Disorder(of)
      • hemorrhagic NEC
        • due to
          • intrinsic
            • circulating anticoagulants
    • Disorder(of)
      • hemorrhagic NEC
        • due to
          • intrinsic
            • increase in
              • antithrombin
    • Disorder(of)
      • hemorrhagic NEC
        • due to
          • intrinsic
            • increase in
              • anti-VIIIa
    • Disorder(of)
      • hemorrhagic NEC
        • due to
          • intrinsic
            • increase in
              • anti-IXa
    • Disorder(of)
      • hemorrhagic NEC
        • due to
          • intrinsic
            • increase in
              • anti-XIa

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR BLD006
Coagulation and hemorrhagic disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Bleeding Disorders

Normally, if you get hurt, your body forms a blood clot to stop the bleeding. For blood to clot, your body needs cells called platelets and proteins known as clotting factors. If you have a bleeding disorder, you either do not have enough platelets or clotting factors or they don't work the way they should.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D68.318 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
286.59 Ot hem d/t circ anticoag
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D68.318Overview

Is D68.318 a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What is the ICD-9 equivalent of D68.318?

Under the General Equivalence Mappings, other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors converts to ICD-9-CM 286.59 (ot hem d/t circ anticoag). The mapping is a direct match.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.